Corebridge Financial, Inc.: Form 10-Q for the period ended Jun 30, 2026
Filed with the SEC on Aug 5, 2026 and accepted by EDGAR at Aug 5, 2026, 13:20 ET.
Management's discussion and analysis
As filed, 5,391 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For example, the Risk-Based Capital (“RBC”) framework and RBC charges and treatment applicable to our U.S. life insurance
subsidiaries have been a subject of focus for regulators in recent years. In February 2025, the NAIC announced the creation of a new
Risk-Based Capital Model Governance (EX) Task Force (“Task Force”) as part of its efforts to update and strengthen the governance
framework around RBC requirements. The Task Force adopted governing principles in December 2025 and soon after began a
comprehensive gap analysis and consistency assessment of the existing RBC framework to identify potential issues. The work of the
Task Force is ongoing and could result in changes to RBC requirements and calculations in the future, which could affect our capital
planning, investment strategies, reporting obligations and permitted disclosures. Relatedly, the inaugural meeting of the Invested
Assets (E) Task Force took place in March 2026. It was established for the purpose of better understanding investment products with
characteristics that pose unique risks to insurers and developing investment-related solvency policy changes. For example, in July
2026, the Financial Condition (E) Committee of the NAIC approved new Life RBC factors, to be effective December 31, 2026, for
CLOs, collateralized bond obligations (“CBOs”) and collateralized debt obligations (“CDOs”). This framework includes (i) lower RBC
factors for senior investment-grade tranches (NAIC Designation Category 1.A through 1.G) and higher RBC factors for lower rated
tranches (NAIC Designation Category 2.A or below) and (ii) an 11.77% pretax surcharge that will apply to below-investment-grade
tranches (NAIC Designation Category 2.C or below) of only broadly syndicated loan CLOs (not middle market CLOs) with a thickness
of 4% or less. The NAIC and its related working groups continue to consider the treatment of other investment products which would
result in changes to accounting policies and RBC requirements. We are actively monitoring these developments associated with these
RBC-related NAIC initiatives and their potential impacts on our life insurance subsidiaries.
As another example, during 2025, the Life Actuarial Task Force adopted updates to actuarial guidelines intended to enhance asset
adequacy analysis for asset-intensive, life insurance and annuity reinsurance treaties above certain thresholds. The updated
guidelines, referred to as Actuarial Guideline LV (“AG 55”), are designed as a testing and disclosure regime, and the first AG 55
reports were filed in April 2026. The NAIC plans to review the disclosures to identify any concerns with insurers’ approaches to asset
adequacy testing, with the possibility of making additional changes that could lead to higher reserves for certain reinsurance
agreements. We are actively monitoring developments associated with this NAIC initiative, which are applicable to certain
transactions that involve our life insurance subsidiaries acting as cedants.
VM-22 principles-based reserving applicable to non-variable annuity contracts is effective on January 1, 2026, and Companies have
three years to implement VM-22 requirements with mandatory adoption January 1, 2029. The NAIC’s Life Actuarial Task Force VM-22
(A) Subgroup is considering allowing optional election of VM-22 for non-variable annuity business issued on or after January 1, 2017.
Relatedly, the Generator of Economic Scenarios statutory reserve and capital calculations applicable to new non-variable annuity
business is effective January 1, 2026. Corebridge has considered, and will be considering, appropriate implementation of these
frameworks, and continues to closely monitor these developments.
Finally, the NAIC Life Insurance and Annuities (A) Committee has created a working group to contemplate updating NAIC guidance
for life insurance and annuity illustrations and disclosures. Suggested revisions could include changes to illustration requirements for
fixed index annuities pertaining to back-casting performance results. We are monitoring these developments and any model guidance
that may flow from the Life Insurance and Annuities Committee’s work on this subject.
In addition to regulatory developments at the NAIC, we are also subject to accounting practices and standards prescribed and/or
permitted by our domiciliary insurance regulators. In December 2025, the NAIC approved agenda item 2024-06: Risk Transfer
Analysis of Combination Reinsurance Contracts in respect of SSAP No. 61 and Appendix A-791 (the “Adoption”), clarifying the
treatment of combination treaties with interdependent features under statutory accounting for new and newly amended contracts
effective immediately and for in-force contracts effective for the year ending December 31, 2026. In response, we received a statutory
permitted accounting practice from the Texas Department of Insurance related to an existing reinsurance treaty that fell within the
scope of the Adoption. The permitted accounting practice is effective December 31, 2026.
For information regarding our regulation and supervision by different regulatory authorities in the United States and abroad, see
“Business—Regulation—U.S. Regulation” and “Business—Regulation—International Regulation in the 2025 Form 10-K.
Corebridge | Second Quarter 2026 Form 10-Q 85
Market risk
As filed, 209 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Risk
There have been no material changes to the quantitative and qualitative disclosures about market risk described in “Quantitative and
Qualitative Disclosures About Market Risk” in the 2025 Form 10-K.
Controls and procedures
As filed, 1,527 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported
within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to
management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required
disclosures. In connection with the preparation of this Quarterly Report on Form 10-Q, an evaluation was carried out by Corebridge
management, with the participation of Corebridge’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of June 30, 2026.
Based on this evaluation, Corebridge’s Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and
procedures were effective as of June 30, 2026.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f)) that have occurred during
the quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over
financial reporting.
Corebridge | Second Quarter 2026 Form 10-Q 137
Risk factors
As filed, 441 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors discussed in “Risk
Factors” in our 2025 Form 10-K and in our first quarter 2026 Form 10-Q. There have been no material changes in Corebridge’s risk
factors from those disclosed in "Risk Factors" in the 2025 Form 10-K. and in the first quarter 2026 Form 10-Q.
Corebridge | Second Quarter 2026 Form 10-Q 138
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-04-01 to 2026-06-30 | $3.91bn | us-gaap:Revenues |
| Revenue | 6 months2026-01-01 to 2026-06-30 | $7.88bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2026-04-01 to 2026-06-30 | $466.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2026-01-01 to 2026-06-30 | $934.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2026-04-01 to 2026-06-30 | $131.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2026-01-01 to 2026-06-30 | $262.0m | us-gaap:InterestExpense |
| Income tax | 3 months2026-04-01 to 2026-06-30 | $50.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2026-01-01 to 2026-06-30 | $208.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-04-01 to 2026-06-30 | $2.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2026-01-01 to 2026-06-30 | −$51.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-04-01 to 2026-06-30 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2026-01-01 to 2026-06-30 | −$0.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-04-01 to 2026-06-30 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2026-01-01 to 2026-06-30 | −$0.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-04-01 to 2026-06-30 | 454,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2026-01-01 to 2026-06-30 | 463,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2026-01-01 to 2026-06-30 | −$53.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2026-01-01 to 2026-06-30 | $226.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2026-01-01 to 2026-06-30 | $1.55bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-06-30 | $353.0m | us-gaap:Cash |
| Total assets | At period end2026-06-30 | $415.79bn | us-gaap:Assets |
| Total liabilities | At period end2026-06-30 | $404.42bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2026-06-30 | $1.25bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2026-06-30 | $10.65bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001889539-26-000141. Last ingested by Listed: Nov 11, 2026, 01:47 ET. Listed shows no prices and gives no investment advice.